Ardelyx (ARDX) Gross Margin (2015 - 2026)
Ardelyx's (ARDX) quarterly Gross Margin came in at 94.91% in Q1 2026, up 1151.0% YoY from 7.59% in Q1 2025, and up 3.91% on a QoQ basis from 91.34% in Q4 2025.
Ardelyx (ARDX) Gross Margin (2015 - 2026) Analysis & Trends
Ardelyx (ARDX) has 10 years of Gross Margin data on file, last reported at 94.91% in Q1 2026.
- Quarterly Gross Margin rose 1151.0% year-over-year to 94.91% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 90.01% (up 542.0% YoY) and the FY2025 annual result came in at 90.29%, up 545.0% from the prior year.
- Gross Margin rose to 94.91% in Q1 2026, from 91.34% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 94.91% in Q1 2026 to a low of 17.12% in Q3 2025.
- A 5-year average of 80.98% and a median of 85.32% in 2022 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2025 — Gross Margin plunged 10111 bps — and 2026, when it surged 1151 bps.
- Tracing ARDX's Gross Margin over 5 years: stood at 92.84% in 2022, then fell by 8 bps to 85.23% in 2023, then slipped by 1 bps to 84.27% in 2024, then increased by 8 bps to 91.34% in 2025, then rose by 4 bps to 94.91% in 2026.
- The last three Gross Margin figures came in at 94.91% (Q1 2026), 91.34% (Q4 2025), and 17.12% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 95.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95.24% |
| Mar 31, 2026 | 94.91% |
| Dec 31, 2025 | 91.34% |
| Sep 30, 2025 | -17.12% |
| Jun 30, 2025 | 87.30% |
| Mar 31, 2025 | 83.40% |
| Dec 31, 2024 | 84.27% |
| Sep 30, 2024 | 83.99% |
| Jun 30, 2024 | 87.11% |
| Mar 31, 2024 | 84.51% |
| Dec 31, 2023 | 85.23% |
| Sep 30, 2023 | 86.36% |
| Jun 30, 2023 | 84.38% |
| Mar 31, 2023 | 86.48% |
| Dec 31, 2022 | 92.84% |
| Sep 30, 2022 | 85.32% |
| Jun 30, 2022 | 94.54% |
| Mar 31, 2022 | 81.84% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |